AdaptHealth Corp. — Third Quarter 2026 Earnings Summary

AdaptHealth Corp. reported third-quarter 2026 net revenue of $745.6 million, representing a 10.9% increase year-over-year, while net loss attributable to the company rose to $168.2 million due to a $184.8 million pre-tax goodwill impairment. The company cleared regulatory hurdles for the pending $235.0 million sale of its Diabetes Health business, which is expected to close in early 2027, and expanded its capitated portfolio through new agreements with health systems and regional plans. Adjusted EBITDA for the quarter was $141.9 million, and the company revised its full-year 2026 financial guidance to project net revenue between $2.88 billion and $2.90 billion and free cash flow between $50 million and $75 million.